Replies to post #695 on Enanta Pharmaceuticals Inc (ENTA)

[willyw]

Thanks, I blurred slide 17 (EDP-239 NS5A) and added on the slide 18 mention of the cyclophilin inhibitor)

I appreciate the correction, and will add; I always seem to make *at least* one mistake....
.....and you always catch it. : )

Kudos. I really do appreciate it. I only want to get correct information out there.

It will be interesting to see just how good ENTA's NS5a is. I wonder if we will have to wait until EASL or if we'll hear sooner.

~W